Neurologic and Orthopedic Institute of Chicago Offer Complimentary Brain
Scans, Oct 26 & 27, as Part of Clinical Study.
CHICAGO, Oct. 19 /PRNewswire/ --
What: Women diagnosed with HER-2 positive Stage III or Stage IV
breast cancer are eligible to receive an MRI of the brain
at no charge as part of a clinical trial. HER2 is a breast
cancer that tests positive for a protein called human
epidermal growth factor receptor-2 (HER2), which promotes
the growth of cancer cells. Studies have shown that in as
many as 30 percent of breast cancer patients have a
metastasis in the brain. As part of the screening
protocol, participants will undergo a MRI of the brain. The
cost of the MRI is covered by the clinical trial.
Who: Patients who qualify must have an initial primary diagnosis
of high risk and/or HER-2 positive breast cancer. They
must be at least 18 years and should not participate if
they are pregnant.
When: Friday, October 26th, 1 p.m. to 9 p.m.
Saturday, October 27th, 8 a.m. to 5 p.m.
Where: Neurologic and Orthopedic Institute of Chicago
4501 N. Winchester, Chicago
Cost: The brain MRI is free of charge to the patient.
Background: The Chicago Institute of Neurosurgery and Neuroresearch
(CINN) Medical Group will use information from the
screening to determine the potentialbenefit(s) of screening
for brain metastases in patients with advanced breast
Study Selection & Enrollment Criteria
Women must be within three to twenty-four m
|SOURCE Chicago Institute of Neurosurgery and Neuroresearch|
Copyright©2007 PR Newswire.
All rights reserved